Literature DB >> 23145885

Comparison of manual versus automatic continuous positive airway pressure titration and the development of a predictive equation for therapeutic continuous positive airway pressure in Chinese patients with obstructive sleep apnoea.

Jiaying Luo1, Sichang Xiao, Zhihui Qiu, Ning Song, Yuanming Luo.   

Abstract

BACKGROUND AND
OBJECTIVE: Whether the therapeutic nasal continuous positive airway pressure (CPAP) derived from manual titration is the same as derived from automatic titration is controversial. The purpose of this study was to compare the therapeutic pressure derived from manual titration with automatic titration.
METHODS: Fifty-one patients with obstructive sleep apnoea (OSA) (mean apnoea/hypopnoea index (AHI) = 50.6 ± 18.6 events/h) who were newly diagnosed after an overnight full polysomnography and who were willing to accept CPAP as a long-term treatment were recruited for the study. Manual titration during full polysomnography monitoring and unattended automatic titration with an automatic CPAP device (REMstar Auto) were performed. A separate cohort study of one hundred patients with OSA (AHI = 54.3 ± 18.9 events/h) was also performed by observing the efficacy of CPAP derived from manual titration.
RESULTS: The treatment pressure derived from automatic titration (9.8 ± 2.2 cmH(2)O) was significantly higher than that derived from manual titration (7.3 ± 1.5 cmH(2)O; P < 0.001) in 51 patients. The cohort study of 100 patients showed that AHI was satisfactorily decreased after CPAP treatment using a pressure derived from manual titration (54.3 ± 18.9 events/h before treatment and 3.3 ± 1.7 events/h after treatment; P < 0.001).
CONCLUSIONS: The results suggest that automatic titration pressure derived from REMstar Auto is usually higher than the pressure derived from manual titration.
© 2013 The Authors. Respirology © 2013 Asian Pacific Society of Respirology.

Entities:  

Mesh:

Year:  2013        PMID: 23145885     DOI: 10.1111/resp.12014

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  7 in total

1.  Noninvasive auto-titrating ventilation (AVAPS-AE) versus average volume-assured pressure support (AVAPS) ventilation in hypercapnic respiratory failure patients.

Authors:  Gul Gursel; Avsar Zerman; Burcu Basarik; Kamil Gonderen; Muge Aydogdu; Serriyye Memmedova
Journal:  Intern Emerg Med       Date:  2018-03-06       Impact factor: 3.397

2.  Different Continuous Positive Airway Pressure Titration Modalities in Obstructive Sleep Apnea Syndrome Patients.

Authors:  Hadeer Ahmed Elshahaat; Tarek Abd El-Hakeem Mahfouz; Ashraf Elsyed Elshora; Amany Shaker
Journal:  Int J Gen Med       Date:  2021-12-21

3.  Continuous Positive Airway Pressure and Breathlessness in Obese Patients with Obstructive Sleep Apnea: A Pilot Study.

Authors:  Sichang Xiao; Johan Bastianpillai; Culadeeban Ratneswaran; Martino F Pengo; Yuanming Luo; Caroline J Jolley; John Moxham; Joerg Steier
Journal:  Sleep       Date:  2016-06-01       Impact factor: 5.849

Review 4.  Mathematical Equations to Predict Positive Airway Pressures for Obstructive Sleep Apnea: A Systematic Review.

Authors:  Macario Camacho; Muhammad Riaz; Armin Tahoori; Victor Certal; Clete A Kushida
Journal:  Sleep Disord       Date:  2015-07-30

5.  Determination of equation for estimating continuous positive airway pressure in patients with obstructive sleep apnea for the Indian population.

Authors:  Latha Sarma; Nandan Putti; Kapil Alias; Mohit Chilana
Journal:  Lung India       Date:  2020 Sep-Oct

6.  Postoperative secondary aggravation of obstructive sleep apnea-hypopnea syndrome and hypoxemia with bilateral carotid body tumor: A case report.

Authors:  Xi Yang; Xiao-Guang He; Dong-Hui Jiang; Chun Feng; Rui Nie
Journal:  World J Clin Cases       Date:  2020-12-06       Impact factor: 1.337

Review 7.  Year in review 2013: Acute lung injury, interstitial lung diseases, sleep and physiology.

Authors:  Amanda Piper; Yuanlin Song; Neil D Eves; Toby M Maher
Journal:  Respirology       Date:  2014-02-21       Impact factor: 6.424

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.